BMY vs BSRR · P/E 17, rev $24.46B vs P/E 11, rev $11.7M
Bristol-Myers Squibb Company (BMY) versus Sierra Bancorp (BSRR) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Sierra Bancorp (BSRR) is a banks - regional company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported BSRR revenue for 2026-06-30 was $11.7M. Net income was $22.4M. Revenue was down 71.7% from 2026-03-31 to 2026-06-30. BSRR currently screens at market cap $439.4M and trailing P/E 11.2.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. BSRR currently screens at market cap $439.4M and trailing P/E 11.2.
Not investment advice. Open the BMY and BSRR stock pages for the full models.
Not investment advice.